XML 90 R76.htm IDEA: XBRL DOCUMENT v3.24.2
Equity - Warrants - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Mar. 13, 2024
Jan. 12, 2024
Jul. 31, 2023
Apr. 10, 2023
Mar. 01, 2022
Dec. 31, 2023
Dec. 31, 2022
Mar. 12, 2024
Feb. 22, 2024
Mar. 20, 2023
Stockholders Equity Details [Line Items]                    
Warrants to purchase aggregate shares     892,856              
Proceeds from the exercise of warrants     $ 3,000 $ 6,000            
Class of warrant or right, outstanding           7,070,627        
Exercise price       $ 7.5            
Common stock, par value           $ 0.0001 $ 0.0001      
Purchase price of per share     $ 3.5 $ 6.5           $ 83.43
Aggregate purchase price           $ 12,750 $ 30,000      
2024 Warrant Repricing                    
Stockholders Equity Details [Line Items]                    
Exercise price           $ 67.7        
2024 Warrant Repricing | Subsequent Event                    
Stockholders Equity Details [Line Items]                    
Number of warrants repriced   652,981                
Exercise price   $ 2.4898                
Common Stock                    
Stockholders Equity Details [Line Items]                    
Purchase and sale of shares           13,296 265,641      
Common Stock | RWI Forbearance Agreement | Warrants | Subsequent Event                    
Stockholders Equity Details [Line Items]                    
Exercise price $ 5.895                  
Warrants and rights outstanding, expire date Jun. 20, 2028                  
Common Stock | Forbearance Agreement | March 2023 Loan Warrants | Warrants | Subsequent Event | Loan Agreement | CV Starr                    
Stockholders Equity Details [Line Items]                    
Warrants to purchase aggregate shares 75,000                  
Warrant Expiration Date Mar. 17, 2028                  
Exercise price $ 5.895             $ 7.1    
Common Stock | Forbearance Agreement | June 2023 Loan Warrants | Warrants | Subsequent Event | Loan Agreement | CV Starr                    
Stockholders Equity Details [Line Items]                    
Warrants to purchase aggregate shares 50,000                  
Warrant Expiration Date Jun. 20, 2028                  
Exercise price $ 5.895             $ 8.1    
Minimum                    
Stockholders Equity Details [Line Items]                    
Exercise price     3.5              
Maximum                    
Stockholders Equity Details [Line Items]                    
Exercise price     $ 7.5              
Maximum | Common Stock | RWI Forbearance Agreement | Warrants | Subsequent Event                    
Stockholders Equity Details [Line Items]                    
Number of warrants repriced 300,000                  
Class A Common Stock                    
Stockholders Equity Details [Line Items]                    
Warrants to purchase aggregate shares     857,142 923,076   7,070,627        
Purchase and sale of shares     857,142 923,076            
Common stock, par value           $ 0.0001 $ 0.0001      
Class A Common Stock | Subsequent Event                    
Stockholders Equity Details [Line Items]                    
Common stock, par value                 $ 0.0001  
Class A Common Stock | January 2024 PIPE Warrants | Subsequent Event                    
Stockholders Equity Details [Line Items]                    
Aggregate purchase price   $ 6,000                
Class A Common Stock | January 2024 PIPE Warrants | Private Placement | Subsequent Event                    
Stockholders Equity Details [Line Items]                    
Exercise price   $ 2.4898                
Warrants and rights outstanding, expire date   Jan. 16, 2029                
Purchase and sale of shares   2,141,098                
Common stock, par value   $ 0.0001                
Purchase price of per share   $ 1.25                
Warrants and rights issued closing date   Jan. 16, 2024                
Term (years)   5 years                
Class A Common Stock | Maximum | January 2024 PIPE Warrants | Private Placement | Subsequent Event                    
Stockholders Equity Details [Line Items]                    
Warrants to purchase aggregate shares   535,274                
Legacy Celularity                    
Stockholders Equity Details [Line Items]                    
Warrants to purchase aggregate shares         1,328,138          
Number of shares issued         1,328,138          
Issuance cost of equity         $ 15,985          
Legacy Celularity | Minimum                    
Stockholders Equity Details [Line Items]                    
Exercise price         $ 35          
Legacy Celularity | Maximum                    
Stockholders Equity Details [Line Items]                    
Exercise price         $ 75.3          
Legacy Celularity | Class A Common Stock                    
Stockholders Equity Details [Line Items]                    
Proceeds from the exercise of warrants         $ 46,485